The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review
O Kubeček, J Laco, J Špaček, J Petera… - Clinical & experimental …, 2017 - Springer
Secondary tumors of the ovary account for 10–25% of all ovarian malignancies. The most
common tumors that give rise to ovarian metastases include breast, colorectal, endometrial …
common tumors that give rise to ovarian metastases include breast, colorectal, endometrial …
An algorithmic immunohistochemical approach to define tumor type and assign site of origin
AM Bellizzi - Advances in anatomic pathology, 2020 - journals.lww.com
Immunohistochemistry represents an indispensable complement to an epidemiology and
morphology-driven approach to tumor diagnosis and site of origin assignment. This review …
morphology-driven approach to tumor diagnosis and site of origin assignment. This review …
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
MS Anglesio, S Kommoss, MC Tolcher… - The Journal of …, 2013 - Wiley Online Library
Mucinous ovarian carcinomas (MCs) typically do not respond to current conventional
therapy. We have previously demonstrated amplification of HER2 in 6 of 33 (18.2%) …
therapy. We have previously demonstrated amplification of HER2 in 6 of 33 (18.2%) …
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
R Mackenzie, S Kommoss, BJ Winterhoff, BR Kipp… - BMC cancer, 2015 - Springer
Background Mucinous ovarian tumors represent a distinct histotype of epithelial ovarian
cancer. The rarest (2-4% of ovarian carcinomas) of the five major histotypes, their genomic …
cancer. The rarest (2-4% of ovarian carcinomas) of the five major histotypes, their genomic …
Pathologic evaluation of unknown primary cancer
KA Oien - Seminars in oncology, 2009 - Elsevier
The pathologic approach to metastases of unknown primary cancer (UPC) is stepwise and
uses the clinical context, morphology, and, where necessary, immunohistochemistry (IHC) …
uses the clinical context, morphology, and, where necessary, immunohistochemistry (IHC) …
SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type
The primary origin of some ovarian mucinous tumors may be challenging to determine,
because some metastases of extraovarian origin may exhibit gross, microscopic, and …
because some metastases of extraovarian origin may exhibit gross, microscopic, and …
Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study
RJ Zaino, MF Brady, SM Lele, H Michael, B Greer… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Primary mucinous adenocarcinomas of the ovary are uncommon, and their
biological behavior is uncertain. Retrospective studies have suggested that many mucinous …
biological behavior is uncertain. Retrospective studies have suggested that many mucinous …
Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma
LE Kelemen, M Köbel - The lancet oncology, 2011 - thelancet.com
Mucinous carcinomas are uncommon histological types that affect several organ sites.
Primary mucinous carcinomas of the ovary are distinct from other ovarian carcinoma types …
Primary mucinous carcinomas of the ovary are distinct from other ovarian carcinoma types …
Mucinous neoplasms of the ovary: radiologic-pathologic correlation
J Marko, KI Marko, SL Pachigolla, BA Crothers… - Radiographics, 2019 - pubs.rsna.org
Mucinous neoplasms of the ovary account for 10%–15% of ovarian neoplasms. They may
be benign, borderline, or malignant. The large majority are benign or borderline, accounting …
be benign, borderline, or malignant. The large majority are benign or borderline, accounting …
Genome-wide significant risk associations for mucinous ovarian carcinoma
Australian Ovarian Cancer Study Group, H Baker… - Nature …, 2015 - nature.com
Genome-wide association studies have identified several risk associations for ovarian
carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC …
carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC …